Invention Grant
- Patent Title: Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (Tdp1)—topoisomerase I (Top1) inhibitors
-
Application No.: US14868701Application Date: 2015-09-29
-
Publication No.: US09402842B2Publication Date: 2016-08-02
- Inventor: Mark S. Cushman , Trung X. Nguyen , Martin M. Conda-Sheridan , Yves George Pommier
- Applicant: Purdue Research Foundation
- Applicant Address: US IN West Lafayette
- Assignee: Purdue Research Foundation
- Current Assignee: Purdue Research Foundation
- Current Assignee Address: US IN West Lafayette
- Agency: Pearl Cohen Zedek Latzer Baratz LLP
- Agent Mark S. Cohen
- Main IPC: C07D221/18
- IPC: C07D221/18 ; A61K31/473 ; C07D401/06 ; C07D491/056 ; A61K31/4741 ; A61K31/5377
Abstract:
The invention described herein pertains to the synthesis and use of certain N-substituted indenoisoquinoline compounds which inhibit the activity Tyrosyl-DNA Phosphodiesterase I (Tdp1) or Topoisomerase I (Top1) or both, or otherwise demonstrate anticancer activity. Also disclosed are novel N-substituted indenoisoquinoline compounds and pharmaceutical compositions comprising the novel N-substituted indenoisoquinoline compounds.
Public/Granted literature
- US20160081999A1 SYNTHESIS AND USE OF DUAL TYROSYL-DNA PHOSPHODIESTERASE I (Tdp1) - TOPOISOMERASE I (Top1) INHIBITORS Public/Granted day:2016-03-24
Information query
